Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

2014 Report Reveals Opportunities for Stem Cell Product Dominance

Published: Thursday, August 21, 2014
Last Updated: Thursday, August 21, 2014
Bookmark and Share
The Report provides real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition.

Launched June 2014, the market intelligence report “Stem Cell Research Products – Opportunities, Tools, and Technologies” supplies research supply companies with the real-time data necessary to make effective product development decisions, sell effectively to scientists, and take market share from the competition.

In 2006 there were only 17 companies selling stem cell specific products to scientists.  Today, there are now over one hundred companies that offer targeted products for stem cell research, a growth of over 500% in only eight years.  The trend is continuing – there are over one million stem cell researchers worldwide and the number of companies selling stem cell products is accelerating faster than ever.

When asked about this phenomenal growth and its impact on companies selling products to stem cell scientists, BioInformant’s Head of Project Management, Lance Breastgoff, said, “In a cut-throat industry, you need to identify key opportunities before the competition.  Because of the rapidly changing nature of this market, you need to know what is trending now.”

With such intense competition, companies marketing to the stem cell researchers need every advantage to stay ahead and the report, “Stem Cell Research Products – Opportunities, Tools, and Technologies” provides the edge to do this.

This 2014 report is unique in the breadth and depth of input sources that were used to identify industry trends, including:  Stem Cell Patent Databases, Stem Cell Publication Databases, Stem Cell Grant Funding Databases, Product Launch Announcements, Press Releases, International Surveys, and more.

In reference to the “Scientist Survey” contained within the report, Breastgoff said, “The report provides insights into the minds of 289 stem cell researchers worldwide, revealing their needs, technical preferences, and current purchasing decisions.  You can use it to create high-demand products that will have researchers pursuing your products over the competition.”

As the global leader in stem cell industry data, BioInformant has already served most of the world’s leading research product companies, including: BD Biosciences, Corning, Sigma Aldrich, GE Biosciences, Beckman Coulter, Thermo Fischer Scientific, ATCC, Novus Biologicals, GE Biosciences, Novartis, EMD Millipore, Sanofi Aventis, Applied Stem Cell, and others.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Human Stem Cells to Rapidly Generate Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Rapid Generation from Stem Cells
Researchers coax human stem cells to rapidly generate bone and heart muscle by directing stem cells down complex developmental pathways.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!